Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits

大麻酚 神经炎症 神经保护 神经退行性变 医学 神经科学 肌萎缩侧索硬化 痴呆 精神分裂症(面向对象编程) 疾病 药理学 精神科 心理学 病理 大麻
作者
Saurabh Kumar Jha,Vinod Kumar Nelson,P. Suryadevara,Siva Prasad Panda,Chitikela P Pullaiah,Mohana Vamsi Nuli,Mehnaz Kamal,Mohd Imran,Saijyothi Ausali,Mosleh M. Abomughaid,Rashi Srivastava,Rahul Deka,Pingal Pritam,Neha Gupta,Harishankar Shyam,Indrakant K. Singh,Bindhy Wasini Pandey,Saikat Dewanjee,Niraj Kumar Jha,Seid Mahdi Jafari
出处
期刊:Ageing Research Reviews [Elsevier]
卷期号:: 102386-102386
标识
DOI:10.1016/j.arr.2024.102386
摘要

Neurodegenerative disorders (NDs) such as Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis are severe and life-threatening conditions in which significant damage of functional neurons occurs to produce malfunction of psycho-motor functions. NDs are an important cause of death in the elderly population worldwide. These disorders are commonly associated with the progression of age, oxidative stress, and environmental pollutants, which are the major etiological factors. Abnormal aggregation of specific proteins such as α-synuclein, amyloid-β, huntingtin, and tau, and accumulation of its associated oligomers in neurons are the hallmark pathological features of NDs. Existing therapeutic options for NDs are only symptomatic relief and do not address root-causing factors, such as protein aggregation, oxidative stress, and neuroinflammation. Cannabidiol is a non-psychotic natural cannabinoid obtained from Cannabis sativa that possesses multiple pharmacological actions, including antioxidant, anti-inflammatory, and neuroprotective effects in various NDs and other neurological disorders both in vitro and in vivo. Cannabidiol has gained attention as a promising therapeutic drug candidate for the management of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, by inhibiting protein aggregation, free radicals, and neuroinflammation. In parallel, CBD has shown positive results in other neurological disorders, such as epilepsy, depression, schizophrenia, and anxiety, as well as adjuvant treatment with existing standard therapeutic agents. Hence, the present review focuses on exploring the possible molecular mechanisms in controlling various neurological disorders as well as its clinical applications in NDs including epilepsy, depression and anxiety. In this way, the current review will serve as a standalone reference for the researchers working in this area.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
小二郎应助啾啾采纳,获得10
1秒前
Praktika完成签到,获得积分10
1秒前
咕咕咕完成签到,获得积分10
2秒前
2秒前
小小沙完成签到,获得积分10
3秒前
3秒前
显眼包关注了科研通微信公众号
4秒前
6秒前
6秒前
南辰辰发布了新的文献求助10
6秒前
四喜丸子完成签到 ,获得积分10
8秒前
Leoling完成签到,获得积分10
8秒前
汉堡包应助勤恳的若翠采纳,获得10
9秒前
爱笑完成签到 ,获得积分10
9秒前
9秒前
张杰完成签到,获得积分10
9秒前
happyvirus发布了新的文献求助10
11秒前
zhulongji发布了新的文献求助30
11秒前
圣人海发布了新的文献求助10
14秒前
zjspidany发布了新的文献求助10
14秒前
16秒前
yanyan完成签到,获得积分10
17秒前
20秒前
20秒前
123.关注了科研通微信公众号
21秒前
qingqing168完成签到,获得积分10
23秒前
啾啾发布了新的文献求助10
24秒前
李爱国应助啾啾采纳,获得10
30秒前
善良又亦完成签到 ,获得积分10
30秒前
春夏秋冬完成签到 ,获得积分10
31秒前
32秒前
香蕉觅云应助科研通管家采纳,获得10
33秒前
萧水白应助科研通管家采纳,获得10
33秒前
研友_VZG7GZ应助科研通管家采纳,获得10
33秒前
斯文败类应助科研通管家采纳,获得10
33秒前
SciGPT应助科研通管家采纳,获得10
33秒前
33秒前
小二郎应助科研通管家采纳,获得10
34秒前
小蘑菇应助科研通管家采纳,获得10
34秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger Heßler, Claudia, Rud 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 1000
Natural History of Mantodea 螳螂的自然史 1000
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
How Maoism Was Made: Reconstructing China, 1949-1965 800
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 量子力学 冶金 电极
热门帖子
关注 科研通微信公众号,转发送积分 3316053
求助须知:如何正确求助?哪些是违规求助? 2947746
关于积分的说明 8538269
捐赠科研通 2623822
什么是DOI,文献DOI怎么找? 1435514
科研通“疑难数据库(出版商)”最低求助积分说明 665607
邀请新用户注册赠送积分活动 651454